Skip to content

New EACS treatment guidelines strike balance between individual choice and public health, say writers

New EACS treatment guidelines strike balance between individual choice and public health, say writers

New drugs will bring revolution in hepatitis C treatment

Heiner Wedemeyer, Hannover Medical School, at EACS 2013. Photo by Liz Highleyman, hivandhepatitis.com

Eastern Europe facing quadruple epidemic while governments do nothing, warns UN Special Envoy

UN Secretary General's Special Envoy on HIV in eastern Europe and central Asia, Professor Michel Kazatchkine, speaking at the opening plenary session of the 14th European AIDS Conference. Photo by Liz Highleyman, hivandhepatitis,com

Predicting response to acute hepatitis C treatment in HIV/HCV co-infected people

Daclatasvir works well against hepatitis C either with interferon or in all-oral regimen

Liver fibrosis linked to immune activation in HIV/HCV co-infected women

Andrea Kovacs, from the Keck School of Medicine in Los Angeles, speaking at the ID Week Conference.

Liver cancer often diagnosed late with poor survival in people with HIV

Juan Berenguer, from Hospital Gregorio Marañón, speaking at ICAAC 2013.

Is HCV infection spreading among HIV-positive gay men in Japan?

Treating HCV genotypes 2 and 3 in HIV/HCV co-infected people

Paola Nasta, from Spedali Civili di Brescia, presenting at ICAAC 2013.